ESR1 and metastatic neoplasm: The ability of MBZ to reduce HIF-regulated gene expression in both estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA_MB-231/SUM-159) cells adds to the versatility of MBZ [39] as an agent that reduces tumor growth and prevents metastatic disease.